Literature DB >> 34523057

Knockdown of Golgi Stress-Responsive Caspase-2 Ameliorates HLD17-Associated AIMP2 Mutant-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation.

Arisa Ochiai1, Sui Sawaguchi1, Shiori Memezawa1, Yoichi Seki1, Takako Morimoto1, Hiroaki Oizumi2, Katsuya Ohbuchi2, Masahiro Yamamoto2, Kazushige Mizoguchi2, Yuki Miyamoto3, Junji Yamauchi4,5.   

Abstract

Hypomyelinating leukodystrophy 17 is an autosomal recessive disease affecting myelin-forming oligodendroglial cells in the central nervous system. The gene responsible for HLD17 encodes aminoacyl-tRNA synthase complex-interacting multifunctional protein 2, whose product proteins form a scaffold that supports aminoacyl-tRNA synthetases throughout the cell body. Here we show that the HLD17-associated nonsense mutation (Tyr35-to-Ter [Y35X]) of AIMP2 localizes AIMP2 proteins as aggregates into the Golgi bodies in mouse oligodendroglial FBD-102b cells. Wild type AIMP2 proteins, in contrast, are distributed throughout the cell body. Expression of the Y35X mutant proteins, but not the wild type proteins, in cells upregulates Golgi stress signaling involving caspase-2 activation. Cells expressing the wild type proteins exhibit differentiated phenotypes with web-like structures bearing many processes following the induction of differentiation, whereas cells expressing the Y35X mutant proteins fail to differentiate. Furthermore, CASP2 knockdown but not control knockdown reverses the phenotypes of cells expressing the mutant proteins. These results suggest that HLD17-associated AIMP2 mutant proteins are localized in the Golgi bodies where their proteins stimulate Golgi stress-responsive CASP2 to inhibit differentiation; this effect is ameliorated by knockdown of CASP2. These findings may reveal some of the molecular and cellular pathological mechanisms underlying HLD17 and possible approaches to ameliorating the disease's effects.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AIMP2; Differentiation; Golgi stress; Hypomyelinating leukodystrophy; Oligodendrocyte; Pelizaeus-Merzbacher disease

Mesh:

Substances:

Year:  2021        PMID: 34523057     DOI: 10.1007/s11064-021-03451-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  1 in total

1.  Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.

Authors:  Naoto Matsumoto; Natsumi Watanabe; Noriko Iibe; Yuriko Tatsumi; Kohei Hattori; Yu Takeuchi; Hiroaki Oizumi; Katsuya Ohbuchi; Tomohiro Torii; Yuki Miyamoto; Junji Yamauchi
Journal:  Biochem Biophys Rep       Date:  2019-11-07
  1 in total
  3 in total

1.  Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen.

Authors:  Sui Sawaguchi; Kenji Tago; Hiroaki Oizumi; Katsuya Ohbuchi; Masahiro Yamamoto; Kazushige Mizoguchi; Yuki Miyamoto; Junji Yamauchi
Journal:  Neurol Int       Date:  2021-12-22

2.  Hypomyelinating Leukodystrophy 8 (HLD8)-Associated Mutation of POLR3B Leads to Defective Oligodendroglial Morphological Differentiation Whose Effect Is Reversed by Ibuprofen.

Authors:  Sui Sawaguchi; Rimi Suzuki; Hiroaki Oizumi; Katsuya Ohbuchi; Kazushige Mizoguchi; Masahiro Yamamoto; Yuki Miyamoto; Junji Yamauchi
Journal:  Neurol Int       Date:  2022-02-16

3.  Case Report: Mutation in AIMP2/P38, the Scaffold for the Multi-Trna Synthetase Complex, and Association With Progressive Neurodevelopmental Disorders.

Authors:  Mahta Mazaheri; Mahdie Yavari; Hadi Zare Marzouni; Angela Stufano; Piero Lovreglio; Simona S'Amore; Hamid Reza Jahantigh
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.